Fulvestrant
anticancer hormone therapy
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
Fulvestrant belongs to the 'anticancer hormone therapy' category. This treatment acts on the hormones that stimulate certain tumours, in the management of hormone-dependent cancers.
Specifically, for Fulvestrant: Treats a hormone-dependent cancer. It is most often a long-term treatment, taken at regular times over long periods; its benefit is judged over time, not by how you feel on a given day.
Under which brands it is found
In France, about 10 reimbursable presentations containing Fulvestrant are recorded. It comes under various trade names and in generic form.
- Faslodex
- Fulvestrant Accord
- Fulvestrant Arrow
- Fulvestrant Biogaran
- Fulvestrant Eg
- Fulvestrant Hikma
- Fulvestrant Mylan
- Fulvestrant Sandoz
- and other presentations
Original brand-name products and generics deliver the same active substance; the choice between them is made with your doctor or pharmacist.
Do you need a supplement? No.
Nothing to add here. Fulvestrant falls under none of our products, and no single-ingredient supplement is credibly warranted as support. Rather than placing a product on principle, we leave this page without a purchase recommendation. If you are otherwise on a statin, an antidiabetic, a PPI, a contraceptive or a beta-blocker, that is where we can be useful.
Related molecules
To explore in the « Other areas » family and its neighbours.